Latest News and Press Releases
Want to stay updated on the latest news?
-
White Oak, Md., May 08, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a final guidance for industry, Postapproval Pregnancy Safety Studies, with recommendations on...
-
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted...
-
ATLANTA, May 08, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to...
-
Her Bodhi scam or legit? KSM-66 Ashwagandha, Black Cohosh, Red Clover ingredients, side effects, pricing, and refund terms for women 2026.
-
Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Pregnancy Detection Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...
-
Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...
-
Hyderabad, India, May 08, 2026 (GLOBE NEWSWIRE) -- According to the latest report by Mordor Intelligence, the femtech market size is projected to grow from USD 9.78 billion in 2026 to USD 18.98...
-
Presgera scam or legit? Ingredients, neuropathy claims, side effects guidance, and refund terms evaluated from the official label.
-
Successfully dosed all four planned healthy volunteer SAD cohorts of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data Preliminary pharmacokinetic (PK) modeling from...
-
‒ Q1 2026 Net Revenue of $723 million; GAAP Net Income of $62 million; Diluted Income per Share of $0.19 ‒‒ Adjusted EBITDA of $202 million; Adjusted Diluted EPS of $0.27 ‒‒ No Change from Preliminary...